Regulatory News:

THERACLION (Alternext, FR0010120402 – ALTHE) (Paris:ALTHE), a company specialized in leading-edge medical equipment for echotherapy, today announced the expansion of the insurance coverage in Germany to the Heilfürsorge Bundespolizei and the launch of a new echotherapy center in the Hong Kong Sanatorium & Hospital in Hong Kong, China. Theraclion also announced that the Echopulse® device has been honored as Silver Stevie Awards in the "Best New Health & Pharmaceutical Product" category of the 2017 International Business Awards.

Expansion of the insurance coverage in Germany

Theraclion recently announced the signature by the BKK Landesverband Nordwest, a German insurance company union, of the integrated care contract covering echotherapy for both fibroadenoma and benign thyroid nodules. In the frame of this agreement, the Heilfürsorge Bundespolizei will now be covering all officials of the federal police for the treatment of breast fibroadenoma or thyroid nodules with echotherapy.

“It is a strong mark of recognition for our technology that the German federal police force now joins the integrated care contract to cover all their officials”, explained Anja Kleber, VP Marketing and Market Access of Theraclion. This new contractual member is an additional step in the generalization of access to echotherapy.”

First Echotherapy treatments for thyroid nodules done in the Hong Kong Sanatorium & Hospital

The top private hospital in Hong Kong and Asia, Hong Kong Sanatorium & Hospital (HKSH), is now the second hospital after Queen Mary Hospital to treat patients with thyroid nodules with echotherapy in Hong Kong, China. Hong Kong Sanatorium & Hospital not only serves local patients from Hong Kong, but also serves a great number of patients from Mainland China. Dr. William Wei, Director of Li Shu Pui ENT Head and Neck Surgery Centre, Hong Kong Sanatorium & Hospital, the former Professor at the Department of Surgery, University of Hong Kong who has carried out this procedure said: “Echotherapy can provide an alternative medical solution to those patients who want their thyroid diseases treated but don’t wish to undergo surgery and to be left a scar on the neck, and more importantly, want to preserve their thyroid gland to avoid life-long medication”. HKSH, which is one of Asia most famous oncology center, will hopefully be Theraclion’s first private hospital reference site for Asia for benign thyroid nodule treatments. “Echotherapy is already used in daily practice at Queen Mary Hospital where Dr. Lang and his team have performed more than 180 treatments in about a year. This treatment done in HKSH is a key milestone in the development of the private high-end market in Asia for us. It will also become our strategic partners in Hong Kong, and the whole China where echotherapy can be a transforming solution,” says Sylvain Yon, Deputy CEO and VP Asia of Theraclion.

Award of the Silver Stevie Award

After having won the German Stevie award in early 2017, Theraclion is now awarded internationally by the Silver Stevie Award for its Echopulse®, its non-invasive solution for the treatment of fibroadenomas and benign thyroid nodules, in the "Best New Health & Pharmaceutical Product" category

Every year this prize is awarded to companies, organizations, or individuals for their outstanding achievements. The award ceremony will take place in Barcelona (Spain) on October 21, 2017.

"We are very proud to be awarded the Silver 2017 Stevie Award," said David Caumartin, CEO of Theraclion. "This prestigious award along with the extended adoption of echotherapy by German organizations and its daily uses in Hong Kong confirm that we have developed a groundbreaking alternative to the invasive treatment methods for benign nodules of breast and thyroid with Echopulse®. We are convinced that this approach will be a promising option for cancer therapy."

About the BKK Landesverband Nordwest

The BKK Landesverband Nordwest (LV NW) comprises 21 insurance companies, which together cover approximately 3 million insured people mainly in the Northwest of Germany but also all over the country. The LV NW is in charge of designing contract policies and organizing regional care.

About the Stevie Award Ceremony

The Stevie Awards ceremony, which was awarded for the first time in 2002, is one of the world's leading prizes and is aimed for international companies of all sizes. Today, the Stevie Awards consist of six different programs, competing around the world. For more information, please visit www.stevieawards.com

About Theraclion

Theraclion is a French company specializing in high-tech medical equipment using therapeutic ultrasound. Drawing on leading-edge technologies, Theraclion has designed and manufactured an innovative solution for echotherapy, the Echopulse®, allowing non-invasive tumor treatment through ultrasound-guided high-intensity focused ultrasound. Theraclion is ISO 13485 certified and has received the CE mark for non-invasive ablation of breast fibroadenomas and thyroid nodules. Based in Malakoff, near Paris, France Theraclion has brought together a team of 34 people, 50% of whom are dedicated to R&D and clinical trials. For more information, please visit Theraclion’s website: www.theraclion.com

Theraclion is listed on Alternext Paris
PEA-PME eligible
Mnemonic: ALTHE - ISIN Code: FR0010120402